Another possibility of how disruption of ER localized molecular chaperone expression may link to obesity and/or BD is increased expression of vesicle monoamine transporter 2 (VMAT2), which concentrates monoamine neurotransmitters into synaptic vesicles. The gene discussed is SLC18A2; the disease is obesity disorder.